Norbert G. Riedel, Ph.D. currently serves as president and CEO of Aptinyx Inc., as well as a member of the company’s board of directors. He was formerly president and CEO of Naurex Inc., the predecessor company acquired by Allergan and from which Aptinyx Inc. and its technology were spun out. Prior to Naurex Inc., Dr. Riedel was Corporate Vice President and Chief Science and Innovation Officer of Baxter International Inc., a diversified healthcare company, from March 2001 until January 2013. From 1998 to 2001, Dr. Riedel served as President and General Manager of the recombinant therapeutic proteins business unit and Vice President of Research and Development at Baxter’s bioscience business. Prior to joining Baxter, from 1996 to 1998, he was head of worldwide biotechnology and worldwide core research functions at Hoechst-Marion Roussel, now Sanofi, a global pharmaceutical company. Previously, he held a series of scientific management positions at Hoechst-Marion Roussel and Hoechst AG.
Dr. Riedel is a member of the Board of Directors of Jazz Pharmaceuticals, ARIAD Pharmaceuticals, and the Illinois Biotechnology Industry Organization. He also serves on the Advisory Board of Northwestern University’s Kellogg School of Management Center for Biotechnology. Most recently, he was appointed by Illinois Governor Pat Quinn to the Illinois Innovation Council.
From 1999 to 2010, Dr. Riedel was a member of the Board of Directors of Oscient Pharmaceuticals Corporation, a biopharmaceutical company, and its predecessor company, Genome Therapeutics Corporation, a genomics company. Dr. Riedel was a member of the Supervisory Board of MediGene AG, a biotechnology company from 2003 to 2013.
Dr. Riedel was postdoctoral fellow at Harvard University from 1984 to 1987 and an Assistant Professor and Associate Professor of medicine and biochemistry at Boston University School of Medicine from 1987 to 1991. Dr. Riedel was also a was a visiting professor at Massachusetts Institute of Technology in 1992, and in 2009, Dr. Riedel was elected as member of the Austrian Academy of Sciences. Dr. Riedel is currently an adjunct professor at Boston University School of Medicine, and an adjunct professor of Medicine at Northwestern University’s Feinberg School of Medicine.
Dr. Riedel received his Diploma in biochemistry from the University of Frankfurt in 1981 and his Ph.D. in biochemistry from the University of Frankfort in 1983.